Acute Aggression After Progesterone Discontinuation in a Young Woman

References (19)

1. Reynolds TA, Makhanova A, Marcinkowska UM, et al. Progesterone and women’s anxiety across the menstrual cycle. Horm Behav. 2018;102:34–40. PubMed CrossRef
2. Glick ID, Bennett SE. Psychiatric complications of progesterone and oral contraceptives. J Clin Psychopharmacol. 1981;1(6):350–367. PubMed CrossRef
3. Kanes SJ, Colquhoun H, Doherty J, et al. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression. Hum Psychopharmacol. 2017;32(2):e2576. PubMed CrossRef
4. Meltzer-Brody S, Colquhoun H, Riesenberg R, et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392(10152):1058–1070. PubMed CrossRef
5. Petta CA, Faúndes A, Dunson TR, et al. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. effects on ovarian function. Fertil Steril. 1998;70(5):817–820. PubMed CrossRef
6. Wenzl R, van Beek A, Schnabel P, et al. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Contraception. 1998;58(5):283–288. PubMed CrossRef
7. Brambilla F, Speca A, Pacchiarotti I, et al. Hormonal background of physiological aggressiveness in psychologically healthy women. Int J Psychophysiol. 2010;75(3):291–294. PubMed CrossRef
8. Ziomkiewicz A, Pawlowski B, Ellison PT, et al. Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue. Biol Psychol. 2012;91(3):376–382. PubMed CrossRef
9. Craig MC, Mulder LM, Zwiers MP, et al. Distinct associations between fronto-striatal glutamate concentrations and callous-unemotional traits and proactive aggression in disruptive behavior. Cortex. 2019;121:135–146. PubMed CrossRef
10. Gerhard DM, Pothula S, Liu RJ, et al. GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions. J Clin Invest. 2020;130(3):1336–1349. PubMed CrossRef
11. Li YF. A hypothesis of monoamine (5-HT) - Glutamate/GABA long neural circuit: aiming for fast-onset antidepressant discovery. Pharmacol Ther. 2020;208:107494. PubMed CrossRef
12. Lieberman JA, Girgis RR, Brucato G, et al. Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry. 2018;23(8):1764–1772. PubMed CrossRef
13. Belelli D, Bolger MB, Gee KW. Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one. Eur J Pharmacol. 1989;166(2):325–329. PubMed CrossRef
14. Brown ES, Park J, Marx CE, et al. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology. 2014;39(12):2867–2873. PubMed CrossRef
15. Garcia NM, Walker RS, Zoellner LA. Estrogen, progesterone, and the menstrual cycle: a systematic review of fear learning, intrusive memories, and PTSD. Clin Psychol Rev. 2018;66:80–96. PubMed CrossRef
16. Vaiva G, Thomas P, Ducrocq F, et al. Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol Psychiatry. 2004;55(3):250–254. PubMed CrossRef
17. Sunaga T, Cicali B, Schmidt S, et al. Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system. Contraception. 2021;103(4):222–224. PubMed CrossRef
18. Bakken GV, Rudberg I, Christensen H, et al. Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5. Drug Metab Dispos. 2009;37(2):254–258. PubMed CrossRef
19. Lutz JD, VandenBrink BM, Babu KN, et al. Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems. Drug Metab Dispos. 2013;41(12):2056–2065. PubMed CrossRef